AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
3 Min Read

From Rx prices to EHRs: Top stories from the 2015 AMA Interim Meeting

The 2015 AMA Interim Meeting took place this week. Read these highlights from the meeting, and see AMA Wire's® full coverage of the event to learn more.

Interim Meeting
Copy
·
4 Min Read

Physicians call for fairness in drug prices, availability

In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help make prescription drugs more affordable. Physicians also are calling for greater competition in the pharmaceutical industry and transparency in prescription drug prices and costs.

Behavioral Health
Copy
·
5 Min Read

CDC panel shares solutions to combat antibiotic resistance

The Centers for Disease Control and Prevention (CDC) estimates that 2 million U.S. illnesses and 23,000 deaths each year are caused by antibiotic-resistant infections, and these result in an estimated $20 billion in excess health care costs.

Behavioral Health
Copy
·
3 Min Read

AMA calls for ban on DTC ads of prescription drugs and medical devices

Physicians at the AMA Interim Meeting adopted new policy aimed at driving solutions to make prescription drugs more affordable.

Press Releases
Copy
·
3 Min Read

AMA continues efforts to combat antibiotic resistance

The AMA today adopted policy during its Interim Meeting to help combat the spread of antibiotic resistant bacteria in all health care facilities.

Press Releases
Copy
·
3 Min Read

3 answers to know about Sunshine Act data going public

The second release of physicians’ financial data under the Physician Payments Sunshine Act, also known as the Open Payments program, was June 30. Learn the answers to three questions patients or others may ask you about your 2014 financial data.

Medicare & Medicaid
Copy
·
1 Min Read

Physicians move to lower generic prescription drug costs

Physicians at the 2015 AMA Annual Meeting voted to take action to address generic prescription drug increases. The AMA Council on Medical Service is expected to release a report at the 2015 AMA Interim Meeting in November that examines both brand name and generic price increases.

Behavioral Health
Copy
·
2 Min Read

Review financial data before it goes public in June

Physicians have 45 days to review and dispute reports regarding their financial interactions with manufacturers of drugs and medical devices reported under the Physician Payments Sunshine Act. Here’s what you need to know about the process before data is made available to the public in June.

Medicare & Medicaid
Copy
·
2 Min Read

CME cleared from reporting under Sunshine Act

With the release of the 2015 Medicare Physician Fee Schedule final rule Oct. 31, the Centers for Medicare & Medicaid Services (CMS) made it official: funding for independent continuing medical education (CME) will not be subject to reporting under the Physician Payments Sunshine Act as initially proposed by the agency earlier this summer.

Medicare & Medicaid
Copy